Home/Filings/4/0000891293-15-000075
4//SEC Filing

CTI BIOPHARMA CORP 4

Accession 0000891293-15-000075

CIK 0000891293operating

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 8:09 PM ET

Size

8.4 KB

Accession

0000891293-15-000075

Insider Transaction Report

Form 4
Period: 2015-12-23
BIANCO LOUIS A
EVP, Finance & Administration
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2015-12-23+1,600,0001,600,000 total
    Exercise: $1.24Exp: 2025-12-23Common Stock (1,600,000 underlying)
  • Disposition to Issuer

    Common Stock

    2015-12-23236,858669,489 total
Holdings
  • Common Stock

    (indirect: By Trust)
    37
Footnotes (2)
  • [F1]Represents the forfeiture back to CTIC of shares of restricted stock. The restricted shares were originally issued pursuant to a performance-based equity award effective as of January 3, 2012 and subsequently amended. The reporting person agreed to forfeit the restricted shares to the issuer. If a performance goal that had been applicable to such restricted stock is achieved by December 31, 2016, the reporting person will be entitled to the grant of a stock option from CTIC with respect to the same number of shares that would have been issued to the reporting person upon achievement of the goal under the original terms of the reporting person's long-term incentive award.
  • [F2]The option is scheduled to vest in eight semi-annual installments over the four-year period following the grant date, subject to the reporting person's continued employment or service with the issuer through the applicable vesting date.

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000891293

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 8:09 PM ET
Size
8.4 KB